W
GILD icon

Wealthfront’s Gilead Sciences GILD Stock Holding History

Wealthfront’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1.42M Buy
18,382
+1,193
+7% +$90.1K 0.01% 191
2018
Q2 		$1.22M Sell
17,189
-10,264
-37% -$725K 0.01% 212
2018
Q1 		$2.07M Buy
27,453
+5,974
+28% +$475K 0.02% 131
2017
Q4 		$1.54M Sell
21,479
-1,786
-8% -$136K 0.02% 154
2017
Q3 		$1.89M Buy
23,265
+13,007
+127% +$995K 0.02% 118
2017
Q2 		$726K Buy
10,258
+102
+1% +$6.79K 0.01% 204
2017
Q1 		$690K Buy
10,156
+865
+9% +$60.8K 0.01% 172
2016
Q4 		$665K Sell
9,291
-6,033
-39% -$448K 0.01% 153
2016
Q3 		$1.21M Buy
15,324
+913
+6% +$74.2K 0.03% 91
2016
Q2 		$1.2M Sell
14,411
-6,941
-33% -$616K 0.03% 86
2016
Q1 		$1.96M Buy
21,352
+3,750
+21% +$338K 0.06% 60
2015
Q4 		$1.78M Sell
17,602
-631
-3% -$65.7K 0.06% 57
2015
Q3 		$1.79M Buy
18,233
+3,005
+20% +$334K 0.07% 54
2015
Q2 		$1.78M Buy
15,228
+5,848
+62% +$639K 0.07% 36
2015
Q1 		$920K Buy
9,380
+1,403
+18% +$142K 0.04% 42
2014
Q4 		$752K Sell
7,977
-481
-6% -$49.7K 0.04% 49
2014
Q3 		$900K Buy
8,458
+2,412
+40% +$236K 0.06% 37
2014
Q2 		$531K Buy
6,046
+4,963
+458% +$386K 0.05% 38
2014
Q1 		$80K Buy
+1,083
New +$84.9K 0.01% 172

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealthfront's GILD Position: Q3 2018 in Review

Wealthfront increased its Gilead Sciences (GILD) stake by 6.9% in Q3 2018, buying an estimated $90.1K and bringing the position to 18,382 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #191.

Wealthfront first reported a position in GILD in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.07M in Q1 2018. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Wealthfront held 18,382 shares of Gilead Sciences worth $1.42M as of Q3 2018.
  • Wealthfront bought 1,193 Gilead Sciences shares in Q3 2018, an estimated $90.1K.
  • Gilead Sciences made up 0.01% of Wealthfront's portfolio in Q3 2018, its #191 holding.
  • Wealthfront first reported a position in Gilead Sciences in Q1 2014 and has held it in 19 quarters since.
  • Wealthfront's Gilead Sciences position peaked at $2.07M in Q1 2018.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.